Risk factor
Very high price volatility
Profitability factor
Favourable analyst view
About
HeartBeam, Inc., a medical technology company, primarily focuses on telemedicine solutions for the detection and monitoring of cardiac disease outside a healthcare facility setting. The company also focuses on providing diagnostic data to physicians with care management of patients with cardiovascular disease. Its telehealth product comprises a credit card sized electrocardiogram machine and a cloud-based...
Company Valuation
From both historical and forecast perspectives, the stock is considerably overpriced compared to similar stocks.
Target Price
The average target price of BEAT is 4.3 and suggests 476% upside potential. Usually, this means a BUY recommendation among investment firms, or a recommendation to increa
Buy
Sell